TAIKO PHARMACEUTICAL CO.,LTD. · 大幸薬品株式会社
Last · Tokyo¥265.00+2.00 (+0.76%)close · yahoo · 13h ago
Market cap¥13.3B50.3M sh
P/E · TTM19.4fwd 57.6 · eps 13.68
Beta0.32vs S&P 500
Div yield1.35%annual · TTM
52w range
¥246.00¥317.00
Volume180.3Ksession
| Revenue | ¥6.4B |
|---|---|
| Operating income | ¥459.0M |
| Net income | ¥923.0M |
| Free cash flow | ¥475.0M |
| Operating margin | 7.2% |
| Net margin | 14.4% |
| Return on equity | 11.3% |
| Period | 2025 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2024-03-28
- Operating Cf Burn
- Net Margin Sharply Negative
Red flags
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -59.0%